Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Calcium Channel Blockers for Hypertension Management

Introduction to Calcium Channel Blockers

  • The American College of Cardiology recommends long-acting dihydropyridine calcium channel blockers, such as amlodipine, nifedipine, and felodipine, as first-line agents for treating hypertension, along with non-dihydropyridine CCBs like diltiazem and verapamil 1, 2

Types of Calcium Channel Blockers and Their Effects

  • Felodipine is a long-acting dihydropyridine CCB with primarily vascular effects, dosed at 5-10 mg once daily 3
  • Isradipine is a medium-duration dihydropyridine CCB, dosed at 2.5-10 mg twice daily 3
  • Nicardipine is a short-acting dihydropyridine CCB, dosed at 20-40 mg three times daily 3
  • Nisoldipine is a short-acting dihydropyridine CCB, dosed at 20-40 mg once daily 3
  • Nitrendipine is a medium-duration dihydropyridine CCB, dosed at 20 mg once or twice daily 3, 4
  • Diltiazem is a non-dihydropyridine CCB that affects both vascular smooth muscle and cardiac conduction, dosed at 120-360 mg once daily 3
  • Verapamil is a non-dihydropyridine CCB with significant effects on cardiac conduction and contractility, dosed at 120-480 mg once daily 3, 4

Mechanism of Action and Clinical Use

  • Dihydropyridine CCBs have more pronounced effects on vascular smooth muscle than on cardiac conduction, leading to peripheral arterial vasodilation 3
  • Non-dihydropyridine CCBs have more significant effects on cardiac conduction and contractility 3
  • CCBs are recommended as first-line agents for hypertension treatment by major guidelines, and can be used as monotherapy or in combination with other antihypertensive drugs 1, 2, 5

Combination Therapy and Special Populations

  • CCBs are often combined with ACE inhibitors or ARBs for enhanced efficacy, and can reduce the incidence of peripheral edema 6, 5
  • In patients with diabetes and albuminuria, ACE inhibitors or ARBs are preferred first-line, with CCBs as add-on therapy 5, 7
  • For resistant hypertension, a combination of a diuretic, CCB, and ACE inhibitor/ARB is recommended, with consideration of adding a mineralocorticoid receptor antagonist if needed 8
  • Long-acting nifedipine can be used for hypertension in pregnancy when needed 5
  • CCBs are effective but may be second-line to ACE inhibitors/ARBs in patients with albuminuria 5, 7
  • Both dihydropyridine and non-dihydropyridine CCBs are effective for patients with hypertension and stable ischemic heart disease 2

Side Effects and Precautions

  • Constipation is a common side effect of verapamil 3
  • Avoid short-acting nifedipine for hypertension due to risk of reflex tachycardia 4
  • Use CCBs with caution in heart failure, particularly non-dihydropyridines 3
  • Verapamil and diltiazem should be avoided in patients with severe left ventricular dysfunction 3